SPDR S&P Biotech ETF $XBI Shares Acquired by Lyell Wealth Management LP

Lyell Wealth Management LP increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 22.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,000 shares of the exchange traded fund’s stock after acquiring an additional 6,119 shares during the period. Lyell Wealth Management LP’s holdings in SPDR S&P Biotech ETF were worth $5,203,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of XBI. Associated Banc Corp bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $1,047,000. Integrity Alliance LLC. lifted its holdings in shares of SPDR S&P Biotech ETF by 16.2% during the third quarter. Integrity Alliance LLC. now owns 7,039 shares of the exchange traded fund’s stock valued at $1,110,000 after purchasing an additional 980 shares during the last quarter. GRIMES & Co WEALTH MANAGEMENT LLC boosted its position in shares of SPDR S&P Biotech ETF by 44.9% in the 3rd quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 24,831 shares of the exchange traded fund’s stock worth $3,915,000 after purchasing an additional 7,689 shares in the last quarter. BOCHK Asset Management Ltd bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $552,000. Finally, Signature Equity Partners LLC boosted its position in shares of SPDR S&P Biotech ETF by 1,285.7% in the 3rd quarter. Signature Equity Partners LLC now owns 194 shares of the exchange traded fund’s stock worth $31,000 after purchasing an additional 180 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 1.9%

SPDR S&P Biotech ETF stock opened at $154.97 on Wednesday. The company has a market capitalization of $10.57 billion, a P/E ratio of 11.47 and a beta of 0.87. The stock’s 50 day moving average is $156.14 and its 200 day moving average is $141.86. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.